As of 2025-06-10, the Fair Value of Elite Pharmaceuticals Inc (ELTP) is -0.42 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.58 USD, the upside of Elite Pharmaceuticals Inc is -172.57%.
With the market price of 0.58 USD and our fair value calculation, Elite Pharmaceuticals Inc (ELTP) is not a good investment. Investing in ELTP stocks now will result in a potential loss of 172.57%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 5Y Avg | |
| Net income | -2.24 | 5.09 | 8.04 | 3.56 | 20.11 | 6.91 |
| YoY growth | 75.86% | 327.13% | 58.02% | -55.70% | 464.56% | 173.97% |
| Market Cap (mil) | 619.60 |
| P/E | |
| Forward P/E | 1,362.60x |
| EPS | -0.02 |
| Avg earnings growth rate | 173.97% |
| TTM earnings | -17.99 |